Your browser doesn't support javascript.
loading
The SYNGAP1 3'UTR Variant in ALS Patients Causes Aberrant SYNGAP1 Splicing and Dendritic Spine Loss by Recruiting HNRNPK.
Yokoi, Satoshi; Ito, Takuji; Sahashi, Kentaro; Nakatochi, Masahiro; Nakamura, Ryoichi; Tohnai, Genki; Fujioka, Yusuke; Ishigaki, Shinsuke; Udagawa, Tsuyoshi; Izumi, Yuishin; Morita, Mitsuya; Kano, Osamu; Oda, Masaya; Sone, Takefumi; Okano, Hideyuki; Atsuta, Naoki; Katsuno, Masahisa; Okada, Yohei; Sobue, Gen.
Afiliação
  • Yokoi S; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Ito T; Department of Neurology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.
  • Sahashi K; Department of Neural iPSC Research, Institute for Medical Science of Aging, Aichi Medical University, Aichi 480-1195, Japan.
  • Nakatochi M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Nakamura R; Public Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya 461-8673, Japan.
  • Tohnai G; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Fujioka Y; Department of Neurology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.
  • Ishigaki S; Division of ALS Research, Aichi Medical University, Aichi 480-1195, Japan.
  • Udagawa T; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Izumi Y; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Morita M; Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Kano O; Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
  • Oda M; Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, Japan.
  • Sone T; Division of Neurology, Department of Internal Medicine, Jichi Medical University, Shimotsuke 329-0498, Japan.
  • Okano H; Department of Neurology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan.
  • Atsuta N; Department of Neurology, Vihara Hananosato Hospital, Miyoshi 728-0001, Japan.
  • Katsuno M; Department of Physiology, Keio University School of Medicine, Tokyo 160-0016, Japan.
  • Okada Y; Department of Physiology, Keio University School of Medicine, Tokyo 160-0016, Japan.
  • Sobue G; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
J Neurosci ; 42(47): 8881-8896, 2022 11 23.
Article em En | MEDLINE | ID: mdl-36261283
Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (Syngap1) mRNA at its 3' untranslated region (UTR) and maintains spine maturation. To elucidate the pathologic roles of this mechanism in ALS patients, we identified the SYNGAP1 3'UTR variant rs149438267 in seven (four males and three females) out of 807 ALS patients at the FUS binding site from a multicenter cohort in Japan. Human-induced pluripotent stem cell (hiPSC)-derived motor neurons with the SYNGAP1 variant showed aberrant splicing, increased isoform α1 levels, and decreased isoform γ levels, which caused dendritic spine loss. Moreover, the SYNGAP1 variant excessively recruited FUS and heterogeneous nuclear ribonucleoprotein K (HNRNPK), and antisense oligonucleotides (ASOs) blocking HNRNPK altered aberrant splicing and ameliorated dendritic spine loss. These data suggest that excessive recruitment of RNA-binding proteins, especially HNRNPK, as well as changes in SYNGAP1 isoforms, are crucial for spine formation in motor neurons.SIGNIFICANCE STATEMENT It is not yet known which RNAs cause the pathogenesis of amyotrophic lateral sclerosis (ALS). We previously reported that Fused in sarcoma (FUS), a pathogenic RNA-binding protein in ALS, stabilizes synaptic Ras-GTPase activating protein 1 (Syngap1) mRNA at its 3' untranslated region (UTR) and maintains dendritic spine maturation. To elucidate whether this mechanism is crucial for ALS, we identified the SYNGAP1 3'UTR variant rs149438267 at the FUS binding site. Human-induced pluripotent stem cell (hiPSC)-derived motor neurons with the SYNGAP1 variant showed aberrant splicing, which caused dendritic spine loss along with excessive recruitment of FUS and heterogeneous nuclear ribonucleoprotein K (HNRNPK). Our findings that dendritic spine loss is because of excess recruitment of RNA-binding proteins provide a basis for the future exploration of ALS-related RNA-binding proteins.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article